TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05270213: Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

Sponsor: Riboscience, LLC. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 164 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$1,382,304

Rescue Site Savings

+$911,064

Unlock Full NCT05270213 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05270213 Rescue Dossier →